Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026
Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $0.1333.
Operator: Good afternoon, and welcome to the Eton Pharmaceuticals, Inc. fourth quarter 2025 financial results conference call. At this time, participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that this call is...
